相关实验视频

Updated: Jul 4, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

塞拉利昂多药耐药结核病的分子决定因素

Harriet N A Blankson^1,2,3, Rashidatu Fouad Kamara⁴, Ivan Barilar^1,2

¹Molecular and Experimental Mycobacteriology, Research Center Borstel Leibniz Lung Center, Borstel, Germany.

Microbiology spectrum

|January 30, 2024

概括

塞拉利昂的多药耐药结核病 (MDR-TB) 对一线药物具有很高的耐药性,但没有诺基诺耐药性. 快速诊断至关重要,以防止进一步的耐药性和传播.

科学领域:

基因组学和传染病流行病学.
结核病的分子流行病学
抗微生物药物耐药性的监测监测

背景情况:

多药耐药结核病 (MDR-TB) 构成了全球健康的重大威胁.
了解区域流行病决定因素对于有效的MDR-TB控制至关重要.
塞拉利昂在管理MDR-TB方面面临着挑战.

研究的目的:

确定塞拉利昂的MDR/抗菌素 (RR) 耐药性Mycobacterium结核病综合体 (MTBC) 菌株的耐药性概况,种系和传播动态.
评估对第一线药物,贝达奎林 (BDQ) 和克洛法齐明 (CFZ) 耐药性的流行率.
为了确定MTBC血统和传输集群.

主要方法:

来自塞拉利昂的238种MTBC菌株的全基因组测序.
药物耐药性概况的分析,包括突变.
用单核酸多态 (SNP) 值来确定MTBC血统和传播动态的植物遗传学分析.

主要成果:

26%的菌株对所有一线药物有耐药性;3个菌株对BDQ/CFZ有额外的耐药性.
没有检测到诺基诺隆耐药性,从而保持了当前全口服治疗方案的可行性.
血统4 (L4) 是最普遍的 (62%),其次是血统6 (L6) (21%).
44%的菌株聚集在一起,最大的群体包括北京祖先3菌株.
在10个L6菌株中观察到初级MDR传播.
鉴定了多种药物耐药性突变,包括一些商业测试遗漏的突变.

结论:

在塞拉利昂,大量的MDR-TB菌株对所有一线药物具有抗药性.
诺基诺耐药性的缺失支持使用当前全口服疗法.
尽管BDQ/CFZ的新兴耐药性很低,但需要密切监测.
迫切需要快速诊断和干预,以制MDR-TB的传播,并防止进一步的耐药性发展.

关键词:

结核病菌菌菌的结核病菌的结核病菌.塞拉利昂塞拉利昂多种药物耐药性多种药物耐药性结核病是一种肺结核病.

更多相关视频

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

相关概念视频

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...